[Biological monitoring of treatment with low molecular weight heparin].
Standard protocol for prophylaxis of postoperative thrombosis do not require biologic control examinations, whereas it is probable that biologic surveillance should be a deciding factor for treatment of constituted thromboses. Measurement of anti-Xa activity by chromogenic technics, using the LMWH international system of units, constitutes a logical solution in the present state of our knowledge.
Aiach
M
M
U.E.R. de Biologie expérimentale et humaine, Paris.
D005170:Factor X / Q000032:analysis / Q000037:antagonists & inhibitors*; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D013927:Thrombosis / Q000188:drug therapy*
D006495:Heparin, Low-Molecular-Weight; D005170:Factor X
Surveillance biologique des traitements par les héparines de bas poids moléculaire.